Subscribe To
Driving apparel market is projected to surpass us$ 30 billion by 2033: fact.mr study
High Focus of Driving Apparel Manufacturers on Enhancing Driver Comfort with Technological advancements...
September 21, 2023, 6:00 am
Electric hoist market advancing at 8.5% cagr to reach us$ 1.7 billion valuation by 2033: fact.mr report
Stringent Worker Safety Regulations, Technological advancements, and Automation in Material Handling Eq...
September 21, 2023, 5:43 am
Klaviyo seals premium-priced nasdaq debut, rising over 9%
Klaviyo Inc (NASDAQ:KVYO) sealed a premium-priced market debut on Wednesday, building on its ‘above the range' IPO pricing earlier in the day. The m...
September 21, 2023, 4:19 am
Amazon: the crown jewel isn't aws
Amazon's e-commerce business showed a surprise profit, demonstrating its ability to generate profits whenever it chooses to. The company's fulfillment...
September 21, 2023, 3:45 am
American lithium: long-term offers little risks
American Lithium Corp is a smaller company trying to capitalize on the growing demand for lithium in the EV market. AMLI operates in Nevada and Peru, ...
September 21, 2023, 2:01 am
Lng: australia industrial arbitrator says chevron, unions close to achieving agreements
Australia industrial arbitrator says: Chevron, Unions are on the precipice of achieving historical first enterprise agreements for LNG facilities Disc...
September 21, 2023, 12:24 am
Myr group: classic low-margin, high capital turnover business with production advantages
MYR Group is a low-margin, high-capital turnover business operating in the electric utility infrastructure and construction markets. The company had r...
September 20, 2023, 11:55 pm
Chardan engaged to facilitate nocturne acquisition corporation’s business combination with cognos therapeutics, inc., paving the way for nasdaq listing
WILMINGTON, Del. and INGLEWOOD, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) — Nocturne Acquisition Corporation (NASDAQ:MBTC, MBTCU, MBTCR) (“Nocturne�...
September 20, 2023, 10:35 pm
5e advanced materials to attend d.a. davidson 22nd annual diversified industrials and services conference
HESPERIA, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) — September 20, 2023 (GLOBE NEWSWIRE) – 5E advanc...
September 20, 2023, 10:00 pm
Notice to disregard — nudj health
PASADENA, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) — We are advised by Nudj Health that journalists an...
September 20, 2023, 9:50 pm
: oil futures settle lower after recent run-up to the year’s highs
Oil futures settled lower for a second straight session on Wednesday, easing back after a run-up early this week to the year’s highest prices. “We...
September 20, 2023, 6:45 pm
Apple puts emphasis on gaming with the latest iphone 15 release
Apple (AAPL) is making a push towards gaming with its recent iPhone 15 launch, particularly within the Pro lineup. Apple has incorporated ...
September 20, 2023, 6:41 pm
Svol: the best income etf on the market sells vix futures
SVOL is an income-oriented ETF that sells VIX futures to generate revenue. The fund takes advantage of ...
September 20, 2023, 6:31 pm
Amd: chasing nvidia in the ai race (rating upgrade)
advanced Micro Devices, Inc.'s 4th generation EPYC processors and cloud services drove a nearly doubled...
September 20, 2023, 5:44 pm
Instacart: another ipo hype you should avoid
Instacart's IPO saw shares soar more than 40% on their first day of trading, driven by high demand for new IPO issues. Some shareholders are using the...
September 20, 2023, 5:26 pm
Farmers & merchants bancorp: take advantage of the nearly 10-year low valuation level
Farmers & Merchants Bancorp (F&M Bank) has outperformed the S&P 500 by 16% but remains undervalued. F&M Bank is well-managed, recognized for its safet...
September 20, 2023, 5:14 pm
Crispr therapeutics: ceo targets $25bn valuation - exa-cel approval is first step
CRISPR Therapeutics has a partnership with Vertex over Exa-Cel, a potentially curative therapy for Sickle Cell Disease and beta thalassemia. The FDA w...
September 20, 2023, 5:14 pm
Predicine announces new study published in the new england journal of medicine demonstrating clinical utility of its mrd liquid biopsy assay in supporting genentech’s phase 1 clinical trial of divaras
PredicineBEACON™ and PredicineWES+™ were used to detect and monitor a diverse spectrum of genomic alternations and emerging resistance mechanisms ...
September 20, 2023, 5:12 pm
Predicine announces new study published in the new england journal of medicine demonstrating clinical utility of its mrd liquid biopsy assay in supporting genentech’s phase 1 clinical trial of divaras
PredicineBEACON™ and PredicineWES+™ were used to detect and monitor a diverse spectrum of genomic alternations and emerging resistance mechanisms ...
September 20, 2023, 5:12 pm
Predicine announces new study published in the new england journal of medicine demonstrating clinical utility of its mrd liquid biopsy assay in supporting genentech’s phase 1 clinical trial of divaras
PredicineBEACON™ and PredicineWES+™ were used to detect and monitor a diverse spectrum of genomic alternations and emerging resistance mechanisms ...
September 20, 2023, 5:12 pm